The department shall:
(1) provide draft rules made under this chapter to the advisory board for the advisory board's review;
(2) consult with the advisory board before issuing an additional:
(a) cultivation facility license under Section 4-41a-205; or
(b) pharmacy license under Section 4-41a-1005;
(3) consult with the advisory board regarding fees set by the department that pertain to the medical cannabis program; and
(4) when appropriate, consult with the advisory board regarding issues that arise in the medical cannabis program.